CL logo

Colgate-Palmolive Company (CL) EBITDA

Annual EBITDA:

$4.99B+$290.00M(+6.17%)
December 31, 2024

Summary

  • As of today, CL annual EBITDA is $4.99 billion, with the most recent change of +$290.00 million (+6.17%) on December 31, 2024.
  • During the last 3 years, CL annual EBITDA has risen by +$546.00 million (+12.29%).
  • CL annual EBITDA is now at all-time high.

Performance

CL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLincome statement metrics

Quarterly EBITDA:

$1.25B-$11.00M(-0.87%)
September 30, 2025

Summary

  • As of today, CL quarterly EBITDA is $1.25 billion, with the most recent change of -$11.00 million (-0.87%) on September 30, 2025.
  • Over the past year, CL quarterly EBITDA has dropped by -$5.00 million (-0.40%).
  • CL quarterly EBITDA is now -12.67% below its all-time high of $1.44 billion, reached on June 30, 1987.

Performance

CL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLincome statement metrics

TTM EBITDA:

$5.00B-$5.00M(-0.10%)
September 30, 2025

Summary

  • As of today, CL TTM EBITDA is $5.00 billion, with the most recent change of -$5.00 million (-0.10%) on September 30, 2025.
  • Over the past year, CL TTM EBITDA has dropped by -$174.00 million (-3.36%).
  • CL TTM EBITDA is now -3.36% below its all-time high of $5.17 billion, reached on September 30, 2024.

Performance

CL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+6.2%-0.4%-3.4%
3Y3 Years+12.3%+19.9%+15.4%
5Y5 Years+16.5%+8.7%+11.6%

CL EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+20.8%-4.6%+19.9%-3.4%+17.6%
5Y5-Yearat high+20.8%-4.6%+19.9%-3.4%+17.6%
All-TimeAll-Timeat high+1329.3%-12.7%+133.0%-3.4%+1060.8%

CL EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.25B(-0.9%)
$5.00B(-0.1%)
Jun 2025
-
$1.27B(+2.3%)
$5.00B(-1.0%)
Mar 2025
-
$1.24B(0.0%)
$5.05B(-1.3%)
Dec 2024
$4.99B(+6.2%)
$1.24B(-1.7%)
$5.12B(-1.0%)
Sep 2024
-
$1.26B(-4.2%)
$5.17B(+1.0%)
Jun 2024
-
$1.31B(+0.7%)
$5.12B(+2.6%)
Mar 2024
-
$1.31B(+1.2%)
$4.99B(+4.7%)
Dec 2023
$4.70B(+13.8%)
$1.29B(+6.9%)
$4.76B(+4.8%)
Sep 2023
-
$1.21B(+1.8%)
$4.55B(+3.6%)
Jun 2023
-
$1.19B(+9.7%)
$4.39B(+3.2%)
Mar 2023
-
$1.08B(+0.7%)
$4.25B(-1.2%)
Dec 2022
$4.13B(-7.0%)
$1.07B(+2.5%)
$4.30B(-0.6%)
Sep 2022
-
$1.05B(-0.1%)
$4.33B(-1.9%)
Jun 2022
-
$1.05B(-7.5%)
$4.41B(-1.8%)
Mar 2022
-
$1.13B(+2.9%)
$4.49B(-0.9%)
Dec 2021
$4.44B(-0.2%)
$1.10B(-2.5%)
$4.53B(-1.0%)
Sep 2021
-
$1.13B(0.0%)
$4.58B(-0.6%)
Jun 2021
-
$1.13B(-3.7%)
$4.61B(+0.6%)
Mar 2021
-
$1.17B(+2.0%)
$4.58B(+0.9%)
Dec 2020
$4.45B(+3.9%)
$1.15B(-0.5%)
$4.54B(+1.3%)
Sep 2020
-
$1.16B(+4.8%)
$4.48B(+2.5%)
Jun 2020
-
$1.10B(-2.4%)
$4.37B(+0.6%)
Mar 2020
-
$1.13B(+3.6%)
$4.34B(+1.5%)
Dec 2019
$4.28B(-1.8%)
$1.09B(+4.1%)
$4.28B(+0.5%)
Sep 2019
-
$1.05B(-2.6%)
$4.25B(+0.1%)
Jun 2019
-
$1.07B(+0.9%)
$4.25B(-1.7%)
Mar 2019
-
$1.06B(-0.2%)
$4.32B(-1.9%)
Dec 2018
$4.36B(-2.7%)
$1.07B(+2.2%)
$4.41B(-2.0%)
Sep 2018
-
$1.04B(-9.0%)
$4.50B(-1.7%)
Jun 2018
-
$1.15B(-0.3%)
$4.58B(0.0%)
Mar 2018
-
$1.15B(-0.4%)
$4.58B(+2.3%)
Dec 2017
$4.48B(+1.8%)
$1.16B(+2.8%)
$4.47B(+0.2%)
Sep 2017
-
$1.12B(-2.0%)
$4.46B(-0.3%)
Jun 2017
-
$1.15B(+9.4%)
$4.48B(+0.7%)
Mar 2017
-
$1.05B(-8.6%)
$4.45B(+0.4%)
Dec 2016
$4.40B(-0.4%)
$1.15B(+0.8%)
$4.43B(+0.6%)
Sep 2016
-
$1.14B(+1.8%)
$4.41B(+0.3%)
Jun 2016
-
$1.12B(+8.2%)
$4.39B(+0.1%)
Mar 2016
-
$1.03B(-7.8%)
$4.39B(-0.9%)
Dec 2015
$4.42B(-4.5%)
$1.12B(-0.5%)
$4.43B(-1.4%)
Sep 2015
-
$1.13B(+1.3%)
$4.49B(-1.5%)
Jun 2015
-
$1.11B(+3.6%)
$4.56B(-1.3%)
Mar 2015
-
$1.07B(-9.2%)
$4.62B(-0.9%)
Dec 2014
$4.63B(+1.2%)
$1.18B(-1.3%)
$4.66B(-0.0%)
Sep 2014
-
$1.20B(+2.1%)
$4.66B(+0.8%)
Jun 2014
-
$1.17B(+5.2%)
$4.62B(+0.5%)
Mar 2014
-
$1.11B(-5.8%)
$4.60B(+0.1%)
Dec 2013
$4.57B(+3.1%)
$1.18B(+1.9%)
$4.59B(+0.9%)
Sep 2013
-
$1.16B(+1.0%)
$4.55B(+0.6%)
Jun 2013
-
$1.15B(+3.8%)
$4.53B(+0.9%)
Mar 2013
-
$1.11B(-2.8%)
$4.49B(+0.8%)
Dec 2012
$4.43B(+3.3%)
$1.14B(+0.4%)
$4.45B(+1.9%)
Sep 2012
-
$1.13B(+2.3%)
$4.37B(+1.0%)
Jun 2012
-
$1.11B(+3.4%)
$4.33B(+0.5%)
Mar 2012
-
$1.07B(+1.4%)
$4.31B(+1.1%)
Dec 2011
$4.29B(+3.6%)
$1.06B(-3.0%)
$4.26B(-0.2%)
Sep 2011
-
$1.09B(+0.2%)
$4.27B(+1.0%)
Jun 2011
-
$1.09B(+5.9%)
$4.23B(+1.1%)
Mar 2011
-
$1.03B(-3.7%)
$4.18B(+0.6%)
Dec 2010
$4.14B(+1.1%)
$1.07B(+1.7%)
$4.16B(-1.6%)
Sep 2010
-
$1.05B(+0.7%)
$4.23B(-0.4%)
Jun 2010
-
$1.04B(+3.8%)
$4.25B(+0.9%)
Mar 2010
-
$1.00B(-11.6%)
$4.21B(+2.3%)
Dec 2009
$4.09B(+11.4%)
$1.14B(+6.8%)
$4.12B(+5.0%)
Sep 2009
-
$1.06B(+5.9%)
$3.92B(+3.2%)
Jun 2009
-
$1.00B(+10.3%)
$3.80B(+1.9%)
Mar 2009
-
$910.60M(-3.0%)
$3.72B(+0.9%)
Dec 2008
$3.67B(+12.3%)
$939.00M(-0.2%)
$3.69B(+1.9%)
Sep 2008
-
$941.30M(+0.9%)
$3.62B(+3.9%)
Jun 2008
-
$932.60M(+6.1%)
$3.49B(+4.2%)
Mar 2008
-
$878.60M(+1.1%)
$3.35B(+4.3%)
Dec 2007
$3.27B(+12.8%)
$869.20M(+7.9%)
$3.21B(+3.1%)
Sep 2007
-
$805.20M(+1.5%)
$3.11B(+2.6%)
Jun 2007
-
$793.10M(+6.9%)
$3.03B(+2.0%)
Mar 2007
-
$742.00M(-3.8%)
$2.98B(+2.0%)
Dec 2006
$2.90B(+7.5%)
$771.70M(+6.0%)
$2.92B(+2.6%)
Sep 2006
-
$727.70M(-1.0%)
$2.84B(+1.7%)
Jun 2006
-
$734.80M(+7.6%)
$2.80B(+1.8%)
Mar 2006
-
$683.20M(-2.2%)
$2.75B(+1.1%)
Dec 2005
$2.70B(+6.7%)
$698.30M(+2.8%)
$2.72B(+2.7%)
Sep 2005
-
$679.00M(-0.9%)
$2.64B(+2.3%)
Jun 2005
-
$685.10M(+4.9%)
$2.58B(+0.8%)
Mar 2005
-
$653.10M(+4.2%)
$2.56B(+1.7%)
DateAnnualQuarterlyTTM
Dec 2004
$2.53B(+3.1%)
$627.00M(+1.3%)
$2.52B(-0.2%)
Sep 2004
-
$619.20M(-6.8%)
$2.53B(+0.3%)
Jun 2004
-
$664.60M(+8.7%)
$2.52B(+1.2%)
Mar 2004
-
$611.20M(-3.4%)
$2.49B(+1.0%)
Dec 2003
$2.45B(+5.8%)
$632.90M(+3.4%)
$2.47B(+1.0%)
Sep 2003
-
$612.30M(-3.6%)
$2.44B(+0.8%)
Jun 2003
-
$635.40M(+8.4%)
$2.42B(+1.9%)
Mar 2003
-
$586.20M(-3.7%)
$2.38B(+2.3%)
Dec 2002
$2.32B(+5.6%)
$608.80M(+2.9%)
$2.32B(+2.1%)
Sep 2002
-
$591.90M(+0.1%)
$2.28B(+1.5%)
Jun 2002
-
$591.30M(+11.1%)
$2.24B(+1.7%)
Mar 2002
-
$532.40M(-5.1%)
$2.20B(+0.3%)
Dec 2001
$2.20B(+6.8%)
$560.80M(+0.4%)
$2.20B(+0.9%)
Sep 2001
-
$558.40M(+0.9%)
$2.18B(-5.9%)
Jun 2001
-
$553.30M(+5.4%)
$2.31B(+9.4%)
Mar 2001
-
$525.00M(-3.1%)
$2.11B(+1.7%)
Dec 2000
$2.06B(+8.1%)
$541.80M(-21.9%)
$2.08B(+2.1%)
Sep 2000
-
$693.90M(+96.2%)
$2.04B(+2.2%)
Jun 2000
-
$353.60M(-27.7%)
$1.99B(+21.6%)
Mar 2000
-
$489.00M(-2.1%)
$1.64B(+42.5%)
Dec 1999
$1.90B(+15.3%)
$499.50M(-23.2%)
$1.15B(+76.8%)
Sep 1999
-
$650.20M(-10.2%)
$650.20M(-61.3%)
Dec 1998
$1.65B(+9.7%)
-
-
Dec 1997
$1.51B(+9.2%)
$724.00M(+116.7%)
$1.68B(+23.9%)
Sep 1997
-
$334.10M(+6.6%)
$1.35B(+2.9%)
Jun 1997
-
$313.50M(+2.3%)
$1.32B(+2.6%)
Mar 1997
-
$306.50M(-23.4%)
$1.28B(+3.0%)
Dec 1996
$1.38B(+10.3%)
$400.10M(+35.3%)
$1.25B(+5.4%)
Sep 1996
-
$295.70M(+5.4%)
$1.18B(+5.0%)
Jun 1996
-
$280.50M(+4.1%)
$1.13B(+1.3%)
Mar 1996
-
$269.50M(-19.9%)
$1.11B(-1.3%)
Dec 1995
$1.25B(+6.7%)
$336.40M(+40.8%)
$1.13B(+2.3%)
Sep 1995
-
$238.90M(-10.1%)
$1.10B(-1.5%)
Jun 1995
-
$265.60M(-6.7%)
$1.12B(+3.1%)
Mar 1995
-
$284.60M(-8.6%)
$1.08B(+3.2%)
Dec 1994
$1.17B(+0.7%)
$311.30M(+21.7%)
$1.05B(+4.1%)
Sep 1994
-
$255.70M(+10.4%)
$1.01B(+3.0%)
Jun 1994
-
$231.60M(-7.7%)
$978.50M(+0.3%)
Mar 1994
-
$250.80M(-7.0%)
$975.60M(+2.2%)
Dec 1993
$1.16B(+23.4%)
$269.80M(+19.2%)
$954.30M(+2.5%)
Sep 1993
-
$226.30M(-1.0%)
$931.10M(-3.0%)
Jun 1993
-
$228.70M(-0.3%)
$959.70M(-2.5%)
Mar 1993
-
$229.50M(-6.9%)
$984.70M(-0.6%)
Dec 1992
$943.40M(+22.9%)
$246.60M(-3.3%)
$991.10M(+7.3%)
Sep 1992
-
$254.90M(+0.5%)
$923.30M(+76.3%)
Jun 1992
-
$253.70M(+7.5%)
$523.60M(+12.1%)
Mar 1992
-
$235.90M(+31.9%)
$467.10M(+9.2%)
Dec 1991
$767.80M(+12.8%)
$178.80M(+223.5%)
$427.80M(+5.6%)
Sep 1991
-
-$144.80M(-173.4%)
$405.20M(-44.4%)
Jun 1991
-
$197.20M(+0.3%)
$728.90M(+2.1%)
Mar 1991
-
$196.60M(+25.9%)
$713.60M(+4.8%)
Dec 1990
$680.90M(+27.9%)
$156.20M(-12.7%)
$681.00M(+8.6%)
Sep 1990
-
$178.90M(-1.6%)
$627.30M(+5.6%)
Jun 1990
-
$181.90M(+10.9%)
$593.80M(-65.1%)
Mar 1990
-
$164.00M(+60.0%)
$1.70B(-37.9%)
Dec 1989
$532.54M(+14.7%)
$102.50M(-29.5%)
$2.74B(+627.1%)
Sep 1989
-
$145.40M(-88.7%)
-$520.10M(-198.5%)
Jun 1989
-
$1.29B(+7.2%)
$528.10M(+24.3%)
Mar 1989
-
$1.20B(+138.1%)
$425.00M(+16.9%)
Dec 1988
$464.23M(-4.3%)
-$3.16B(-364.6%)
$363.50M(+231.7%)
Sep 1988
-
$1.19B(+0.6%)
-$276.10M(-632.4%)
Jun 1988
-
$1.19B(+3.9%)
-$37.70M(-117.7%)
Mar 1988
-
$1.14B(+130.1%)
$212.80M(-44.6%)
Dec 1987
$485.19M(+15.1%)
-$3.80B(-365.3%)
$383.90M(-50.8%)
Sep 1987
-
$1.43B(-0.4%)
$779.50M(+23.9%)
Jun 1987
-
$1.44B(+9.4%)
$629.10M(+43.4%)
Mar 1987
-
$1.31B(+138.6%)
$438.60M(+32.0%)
Dec 1986
$421.57M(+20.8%)
-$3.40B(-365.5%)
$332.30M(-47.8%)
Sep 1986
-
$1.28B(+2.8%)
$637.10M(+29.6%)
Jun 1986
-
$1.25B(+3.3%)
$491.40M(+34.0%)
Mar 1986
-
$1.21B(+139.0%)
$366.80M(+32.5%)
Dec 1985
$348.99M(-3.8%)
-$3.10B(-372.7%)
$276.80M(+592.5%)
Sep 1985
-
$1.14B(+1.2%)
-$56.20M(-685.4%)
Jun 1985
-
$1.12B(+0.5%)
$9.60M(-94.3%)
Mar 1985
-
$1.12B(+132.6%)
$167.70M(-43.2%)
Dec 1984
$362.82M(-8.4%)
-$3.43B(-385.5%)
$295.20M(-92.1%)
Sep 1984
-
$1.20B(-6.1%)
$3.73B(+47.6%)
Jun 1984
-
$1.28B(+2.9%)
$2.52B(+102.9%)
Mar 1984
-
$1.24B
$1.24B
Dec 1983
$395.91M(-8.5%)
-
-
Dec 1982
$432.80M(-11.6%)
-
-
Dec 1981
$489.77M(+2.2%)
-
-
Dec 1980
$479.08M
-
-

FAQ

  • What is Colgate-Palmolive Company annual EBITDA?
  • What is the all-time high annual EBITDA for Colgate-Palmolive Company?
  • What is Colgate-Palmolive Company annual EBITDA year-on-year change?
  • What is Colgate-Palmolive Company quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Colgate-Palmolive Company?
  • What is Colgate-Palmolive Company quarterly EBITDA year-on-year change?
  • What is Colgate-Palmolive Company TTM EBITDA?
  • What is the all-time high TTM EBITDA for Colgate-Palmolive Company?
  • What is Colgate-Palmolive Company TTM EBITDA year-on-year change?

What is Colgate-Palmolive Company annual EBITDA?

The current annual EBITDA of CL is $4.99B

What is the all-time high annual EBITDA for Colgate-Palmolive Company?

Colgate-Palmolive Company all-time high annual EBITDA is $4.99B

What is Colgate-Palmolive Company annual EBITDA year-on-year change?

Over the past year, CL annual EBITDA has changed by +$290.00M (+6.17%)

What is Colgate-Palmolive Company quarterly EBITDA?

The current quarterly EBITDA of CL is $1.25B

What is the all-time high quarterly EBITDA for Colgate-Palmolive Company?

Colgate-Palmolive Company all-time high quarterly EBITDA is $1.44B

What is Colgate-Palmolive Company quarterly EBITDA year-on-year change?

Over the past year, CL quarterly EBITDA has changed by -$5.00M (-0.40%)

What is Colgate-Palmolive Company TTM EBITDA?

The current TTM EBITDA of CL is $5.00B

What is the all-time high TTM EBITDA for Colgate-Palmolive Company?

Colgate-Palmolive Company all-time high TTM EBITDA is $5.17B

What is Colgate-Palmolive Company TTM EBITDA year-on-year change?

Over the past year, CL TTM EBITDA has changed by -$174.00M (-3.36%)
On this page